Jump to content

Encore: Correction: Abiraterone + MDV3100 human trial planned, not funded yet


Recommended Posts

A recent post of this topic by Jim Marshall incorrectly reported that human trials of a combination of Zytiga (abiraterone acetate) and MDV3100 have been funded.

In fact, while lab tests have shown that the combo could work, clinical trials in humans are planned, but not yet funded (as of 5 May 2012).

See the corrected article here:


(Thanks to Tony Maxwell)

Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...